SSTR2-targeting therapy in EBV-positive and EBV-negative metastatic nasopharyngeal carcinoma.

Saved in:
Bibliographic Details
Title: SSTR2-targeting therapy in EBV-positive and EBV-negative metastatic nasopharyngeal carcinoma.
Authors: Huang CY; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University Taoyuan 33305, Taiwan., Lin CY; Gynecologic Cancer Research Center, Chang Gung Memorial Hospital at Linkou, Chang Gung University Taoyuan 33305, Taiwan., Lui KW; Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital at Linkou, Chang Gung University Taoyuan 33305, Taiwan., Chao YK; Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Chang Gung Memorial Hospital at Linkou, Chang Gung University Taoyuan 33305, Taiwan., Lee LY; Department of Pathology, Chang Gung Memorial Hospital at Linkou, Chang Gung University Taoyuan 33305, Taiwan., Huang YL; Department of Pathology, Chang Gung Memorial Hospital at Linkou, Chang Gung University Taoyuan 33305, Taiwan., Hsieh CH; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University Taoyuan 33305, Taiwan., Fan HC; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University Taoyuan 33305, Taiwan., Lin AC; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University Taoyuan 33305, Taiwan., Chang KP; Department of Otolaryngology-Head and Neck Surgery, Chang Gung Memorial Hospital at Linkou, Chang Gung University Taoyuan 33305, Taiwan., Lin CY; Department of Radiation, Chang Gung Memorial Hospital at Linkou, Chang Gung University Taoyuan 33305, Taiwan., Wang HM; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University Taoyuan 33305, Taiwan., Chang YS; Department of Microbiology and Immunology, Chang Gung University Taoyuan 33305, Taiwan.; Graduate Institute of Biomedical Sciences, Chang Gung University Taoyuan 33305, Taiwan.; Molecular Medicine Research Center, Chang Gung University Taoyuan 33305, Taiwan., Li HP; Department of Microbiology and Immunology, Chang Gung University Taoyuan 33305, Taiwan.; Graduate Institute of Biomedical Sciences, Chang Gung University Taoyuan 33305, Taiwan.; Molecular Medicine Research Center, Chang Gung University Taoyuan 33305, Taiwan., Hsu CL; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University Taoyuan 33305, Taiwan.; School of Medicine, Chang Gung University Taoyuan 33305, Taiwan.
Source: American journal of cancer research [Am J Cancer Res] 2026 Feb 15; Vol. 16 (2), pp. 496-506. Date of Electronic Publication: 2026 Feb 15 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: e-Century Pub. Corp Country of Publication: United States NLM ID: 101549944 Publication Model: eCollection Cited Medium: Print ISSN: 2156-6976 (Print) Linking ISSN: 21566976 NLM ISO Abbreviation: Am J Cancer Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2156-6976
DOI:10.62347/OLMD6993